Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Calcimedica Ord Shs (CALC)  
$0.44 0.00 (0.00%) as of 4:30 Fri 3/17


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 5,660,000
Market Cap: 2.49(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.4404 - $0.4404
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Graybug Vision is a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of diseases of the retina and optic nerve. Co.'s product candidate, GB-102, is an intravitreal injection of a microparticle depot formulation of sunitinib, a potent inhibitor of neovascular growth and permeability, which are causes of retinal disease. Co.'s second product candidate, GB-401, is an intravitreally administered, proprietary implant formulation containing a prodrug of a beta-adrenergic receptor inhibitor developed to provide a controlled release of the active drug to maintain reduced intraocular pressure, for six months or longer after a single injection.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 4,000 1,363,274 1,505,415 1,505,415
Total Buy Value $15,600 $5,047,430 $5,493,543 $5,493,543
Total People Bought 1 4 7 7
Total Buy Transactions 2 6 58 58
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-15 2023-11-14 2023-05-16 2022-05-16

   
Records found: 131
  Page 5 of 6  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Guerard Frederic Chief Executive Officer   •       •      –    2022-11-24 4 OE $0.00 $0 D/D 65,625 166,297     -
   Breuil Robert S Chief Financial Officer   •       –      –    2022-09-23 4 D $0.97 $1,627 D/D (1,684) 58,895     -
   Breuil Robert S Chief Financial Officer   •       –      –    2022-09-04 4 OE $0.00 $0 D/D 5,000 60,579     -
   Guerard Frederic Chief Executive Officer   •       •      –    2022-08-19 4 D $0.97 $6,398 D/D (6,596) 100,672     -
   Guerard Frederic Chief Executive Officer   •       •      –    2022-08-19 4 OE $0.00 $0 D/D 28,125 107,268     -
   Zamiri Parisa Chief Medical Officer   •       –      –    2022-08-19 4 D $0.97 $2,588 D/D (2,668) 31,084     -
   Zamiri Parisa Chief Medical Officer   •       –      –    2022-08-19 4 OE $0.00 $0 D/D 9,375 33,752     -
   Breuil Robert S Chief Financial Officer   •       –      –    2022-08-19 4 D $0.97 $3,247 D/D (3,347) 55,579     -
   Breuil Robert S Chief Financial Officer   •       –      –    2022-08-19 4 OE $0.00 $0 D/D 9,937 58,926     -
   Breuil Robert S Chief Financial Officer   •       –      –    2022-06-09 4 OE $0.00 $0 D/D 5,000 48,989     -
   Guerard Frederic Chief Executive Officer   •       •      –    2022-05-19 4 D $0.90 $30,058 D/D (33,357) 79,143     -
   Guerard Frederic Chief Executive Officer   •       •      –    2022-05-19 4 OE $0.00 $0 D/D 112,500 112,500     -
   Breuil Robert S Chief Financial Officer   •       –      –    2022-05-19 4 D $0.90 $14,679 D/D (16,290) 43,989     -
   Breuil Robert S Chief Financial Officer   •       –      –    2022-05-19 4 OE $0.00 $0 D/D 39,750 60,279     -
   Zamiri Parisa Chief Medical Officer   •       –      –    2022-05-19 4 D $0.90 $11,825 D/D (13,123) 24,377     -
   Zamiri Parisa Chief Medical Officer   •       –      –    2022-05-19 4 OE $0.00 $0 D/D 37,500 37,500     -
   Breuil Robert S Chief Financial Officer   •       –      –    2022-03-31 4 S $1.25 $2,735 D/D (2,188) 20,529 18%     
   Breuil Robert S Chief Financial Officer   •       –      –    2022-03-31 4 OE $0.00 $0 D/D 5,000 22,717     -
   Breuil Robert S Chief Financial Officer   •       –      –    2021-12-04 4 OE $0.00 $0 D/D 5,000 17,717     -
   Breuil Robert S Chief Financial Officer   •       –      –    2021-09-22 4 S $3.55 $25,854 D/D (7,283) 12,717 63%     
   Breuil Robert S Chief Financial Officer   •       –      –    2021-09-22 4 OE $0.00 $0 D/D 20,000 20,000     -
   Deerfield Partners, Lp *Possible Member of 10% Group   –       –       •   2020-09-29 4 B $16.00 $25,000,000 I/I 1,562,500 1,853,967 1.5 143%     
   Deerfield Partners, Lp *Possible Member of 10% Group   –       –       •   2020-09-29 4 A $0.00 $0 I/I 3,719,213 291,467     -
   Schwarzman Stephen A 10% Owner   –       –       •   2020-09-29 4 B $16.00 $4,000,000 I/I 250,000 1,930,395 1.5 143%     
   Schwarzman Stephen A 10% Owner   –       –       •   2020-09-29 4 A $0.00 $0 I/I 1,680,395 1,680,395     -
  131 Records found
  1  2  3  4  5  6   
  Page 5 of 6
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us